3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
3
Venous Thromboembolism
1
Thoracic Neoplasms
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Noonan Syndrome
1
Neoplasms by Site
1
Neoplasms
1
Lung Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Healthy Participants
1
Colorectal Neoplasms
1
Carcinoma
1
Bronchial Neoplasms
1
Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation
1
Interventions
osimertinib
2
sotorasib
1
cobimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Noonan Syndrome
×
sotorasib
×
Clear all
NCT04959981
2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1
Completed
24 enrolled